Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

1.500 -0.140 (-8.54%)
Streaming Delayed Price Updated: 1:20 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cerus Corporation - Common Stock

< Previous 1 2 3 4 Next >
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors
From Cerus Corporation
Via Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Stephens Annual Investment Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
From Cerus Corporation
Via Business Wire
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
From Cerus Corporation
Via Business Wire
Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021
From Cerus Corporation
Via Business Wire
Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.